Matches in Wikidata for { <http://www.wikidata.org/entity/Q91036763> ?p ?o ?g. }
Showing items 1 to 46 of
46
with 100 items per page.
- Q91036763 description "article scientifique publié en 2018" @default.
- Q91036763 description "artículu científicu espublizáu n'agostu de 2018" @default.
- Q91036763 description "im August 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91036763 description "scientific article published on 01 August 2018" @default.
- Q91036763 description "wetenschappelijk artikel" @default.
- Q91036763 description "наукова стаття, опублікована в серпні 2018" @default.
- Q91036763 name "Rapid Onset of Action in Patients With Moderate-to-Severe Plaque Psoriasis With Halobetasol 0.01%/Tazarotene 0.045% Fixed Combination" @default.
- Q91036763 name "Rapid Onset of Action in Patients With Moderate-to-Severe Plaque Psoriasis With Halobetasol 0.01%/Tazarotene 0.045% Fixed Combination" @default.
- Q91036763 type Item @default.
- Q91036763 label "Rapid Onset of Action in Patients With Moderate-to-Severe Plaque Psoriasis With Halobetasol 0.01%/Tazarotene 0.045% Fixed Combination" @default.
- Q91036763 label "Rapid Onset of Action in Patients With Moderate-to-Severe Plaque Psoriasis With Halobetasol 0.01%/Tazarotene 0.045% Fixed Combination" @default.
- Q91036763 prefLabel "Rapid Onset of Action in Patients With Moderate-to-Severe Plaque Psoriasis With Halobetasol 0.01%/Tazarotene 0.045% Fixed Combination" @default.
- Q91036763 prefLabel "Rapid Onset of Action in Patients With Moderate-to-Severe Plaque Psoriasis With Halobetasol 0.01%/Tazarotene 0.045% Fixed Combination" @default.
- Q91036763 P1433 Q91036763-BDD63A1D-4FF3-4477-B9A3-B231ECE7472D @default.
- Q91036763 P1476 Q91036763-6FB1E547-6335-47EF-AB3F-2FF3AE6EC7A6 @default.
- Q91036763 P2093 Q91036763-01D1BAA5-A088-4AF7-9EFE-0EE8B803B3CF @default.
- Q91036763 P2093 Q91036763-02F7210A-668C-44E1-838A-F336E2DAAB82 @default.
- Q91036763 P2093 Q91036763-5C0E96BF-C44B-497F-86A0-96CA2BB806D8 @default.
- Q91036763 P2093 Q91036763-7DB3B25C-0673-429D-B506-8162D6A6F07C @default.
- Q91036763 P2093 Q91036763-9E6242D2-BF6C-442B-BF9E-A53FA538E0AC @default.
- Q91036763 P2093 Q91036763-EB0CF825-EB01-46C0-8382-6D46AAF23698 @default.
- Q91036763 P2093 Q91036763-F422CDBC-60DF-49AD-B8BB-8B36F643F6A2 @default.
- Q91036763 P304 Q91036763-6185E3FA-76EB-4038-BE75-4AD72B5263B1 @default.
- Q91036763 P31 Q91036763-B10EDA17-4D25-49B7-B674-DFC8CEAC0E7A @default.
- Q91036763 P433 Q91036763-0982AC9C-E50F-440F-948D-BECC95E3FF8E @default.
- Q91036763 P478 Q91036763-DF7ACFE5-C6C6-4B6B-94CB-36836B7CCEDC @default.
- Q91036763 P577 Q91036763-05C6B351-889E-4183-AD2B-5B8739DDAAF3 @default.
- Q91036763 P698 Q91036763-FDB17A2D-8FCF-431B-8B84-1D6DBF6FFE47 @default.
- Q91036763 P921 Q91036763-C80312A5-352C-418D-A32B-3B092FBA519E @default.
- Q91036763 P698 30124725 @default.
- Q91036763 P1433 Q25380091 @default.
- Q91036763 P1476 "Rapid Onset of Action in Patients With Moderate-to-Severe Plaque Psoriasis With Halobetasol 0.01%/Tazarotene 0.045% Fixed Combination" @default.
- Q91036763 P2093 "David Pariser" @default.
- Q91036763 P2093 "Jeffrey L Sugarman" @default.
- Q91036763 P2093 "Leon H Kircik" @default.
- Q91036763 P2093 "Linda Stein Gold" @default.
- Q91036763 P2093 "Radhakrishnan Pillai" @default.
- Q91036763 P2093 "Robert Kang" @default.
- Q91036763 P2093 "Tina Lin" @default.
- Q91036763 P304 "863-868" @default.
- Q91036763 P31 Q13442814 @default.
- Q91036763 P433 "8" @default.
- Q91036763 P478 "17" @default.
- Q91036763 P577 "2018-08-01T00:00:00Z" @default.
- Q91036763 P698 "30124725" @default.
- Q91036763 P921 Q10355321 @default.